Health in Eritrea
1,395 indicators covering health for Eritrea.
| Indicator | Latest | Year | 10-yr change | Rank |
|---|---|---|---|---|
| Deaths in armed conflicts by country, per square kilometre | 0 units per square kilometre | 2023 | — | 55th |
| Deaths in armed conflicts by region, per square kilometre | 0 units per square kilometre | 2023 | — | 55th |
| Maternal mortality ratio | 321.55 deaths per 100,000 live births | 2020 | down 33.0% | 28th |
| Total tetanus - number of reported cases, annual growth rate | -100 % change on previous year | 2024 | unchanged | 95th |
| Reported cases of measles, annual growth rate | -81.48 % change on previous year | 2024 | down 144.7% | 107th |
| Prevalence of HIV, female | 0.2% | 2024 | unchanged | 49th |
| Prevalence of HIV, male | 0.1% | 2024 | down 50.0% | 70th |
| Incidence of HIV, ages 15-49 | 0.18 per 1,000 uninfected population ages 15-49 | 2024 | down 10.0% | 76th |
| Incidence of HIV, all | 0.1 per 1,000 uninfected population | 2024 | down 9.1% | 77th |
| Prevalence of overweight, female | 20.1% | 2022 | up 51.2% | 190th |
| Prevalence of overweight, male | 14.0% | 2022 | up 32.4% | 191st |
| Prevalence of overweight | 17.2% | 2022 | up 43.3% | 192nd |
| Immunization, HepB3 | 95.0% | 2024 | up 1.1% | 53rd |
| HIV/AIDS deaths averted by antiretroviral therapy | 540.91 deaths | 2024 | down 38.5% | 89th |
| HIV/AIDS deaths averted by antiretroviral therapy, per capita | 0.0002 deaths per person | 2024 | down 46.1% | 58th |
| Live Births Surviving to Age 1 | 104.38 | 2100 | down 4.6% | 96th |
| Life expectancy at age 15 | 82.59 years | 2100 | up 1.6% | 162nd |
| Life expectancy at birth, projections | 81.99 years | 2100 | up 1.8% | 161st |
| Incidence of HIV, ages 50+ | 0.1 per 1,000 uninfected population ages 50+ | 2024 | unchanged | 38th |
| Adults (ages 15+) and children (0-14 years) living with HIV | 12,000 | 2024 | down 20.0% | 94th |
| Adults (ages 15+) and children (0-14 years) living with HIV, per | 0.0034 units per person | 2024 | down 30.0% | 68th |
| Incidence of HIV, ages 15-24 | 0.16 per 1,000 uninfected population ages 15-24 | 2024 | down 5.9% | 68th |
| Newborns protected against tetanus | 99.0% | 2024 | up 5.3% | 4th |
| Adults (ages 15+) and children (0-14 years) living with HIV, annual | 0 % change on previous year | 2024 | up 100.0% | 74th |
| Population ages 00-04, female | 12.9% | 2025 | down 10.6% | 39th |
| Population ages 00-04, male | 13.5% | 2025 | down 11.0% | 35th |
| Population ages 05-09, female | 11.9% | 2025 | down 14.8% | 45th |
| Population ages 05-09, male | 12.4% | 2025 | down 15.1% | 40th |
| Population ages 10-14, female | 12.0% | 2025 | down 5.9% | 32nd |
| Population ages 10-14, male | 12.5% | 2025 | down 6.1% | 30th |
| Population ages 15-19, female | 11.7% | 2025 | up 3.0% | 5th |
| Population ages 15-19, male | 12.1% | 2025 | up 2.4% | 5th |
| Population ages 20-24, female | 10.2% | 2025 | up 16.6% | 4th |
| Population ages 20-24, male | 10.6% | 2025 | up 16.0% | 4th |
| Population ages 25-29, female | 8.4% | 2025 | up 19.1% | 34th |
| Population ages 25-29, male | 8.7% | 2025 | up 20.5% | 27th |
| Population ages 30-34, female | 6.1% | 2025 | up 8.5% | 171st |
| Population ages 30-34, male | 6.3% | 2025 | up 12.2% | 172nd |
| Population ages 35-39, female | 5.0% | 2025 | down 5.4% | 209th |
| Population ages 35-39, male | 5.0% | 2025 | up 0.6% | 208th |
| Population ages 40-44, female | 4.1% | 2025 | down 11.5% | 211th |
| Population ages 40-44, male | 3.9% | 2025 | down 7.0% | 213th |
| Population ages 45-49, female | 3.9% | 2025 | down 1.0% | 194th |
| Population ages 45-49, male | 3.6% | 2025 | down 0.3% | 203rd |
| Population ages 50-54, female | 3.5% | 2025 | up 5.9% | 179th |
| Population ages 50-54, male | 3.1% | 2025 | up 5.7% | 191st |
| Population ages 55-59, female | 3.0% | 2025 | up 17.4% | 168th |
| Population ages 55-59, male | 2.6% | 2025 | up 18.0% | 180th |
| Population ages 60-64, female | 2.5% | 2025 | up 20.9% | 169th |
| Population ages 60-64, male | 2.0% | 2025 | up 21.8% | 174th |
| Population ages 65-69, female | 1.8% | 2025 | up 8.6% | 167th |
| Population ages 65-69, male | 1.4% | 2025 | up 0.5% | 177th |
| Population ages 70-74, female | 1.3% | 2025 | up 1.2% | 163rd |
| Population ages 70-74, male | 1.0% | 2025 | down 9.8% | 172nd |
| Population ages 75-79, female | 0.9% | 2025 | up 14.5% | 154th |
| Population ages 75-79, male | 0.7% | 2025 | up 10.1% | 151st |
| Population ages 80 and above, female | 0.8% | 2025 | up 42.3% | 153rd |
| Population ages 80 and above, male | 0.5% | 2025 | up 44.8% | 146th |
| Population ages 00-04, female | 235,209 | 2025 | up 3.5% | 107th |
| Population ages 00-04, male | 240,838 | 2025 | up 3.7% | 108th |